Showing posts with label Harvoni in Chronic Hepatitis C Patients With Advanced Liver Disease. Show all posts
Showing posts with label Harvoni in Chronic Hepatitis C Patients With Advanced Liver Disease. Show all posts
Friday, April 29, 2016

FDA Approves Two Supplemental Indications for Harvoni in Chronic Hepatitis C Patients With Advanced Liver Disease

›
In continuation of my update on  Harvoni (ledipasvir/sofosbuvir) Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S...